Skip to content

    Colorectal Cancer Health Center

    Font Size
    A
    A
    A

    New Stool Test for Colon Cancer Shows Promise

    DNA analysis boosts accuracy rate to more than 90 percent, researchers say

    WebMD News from HealthDay

    By Alan Mozes

    HealthDay Reporter

    WEDNESDAY, March 19, 2014 (HealthDay News) -- A new at-home stool test screens for colorectal cancer with more than 90 percent accuracy, researchers report.

    "That kind of result is really unprecedented for a noninvasive stool-based screening," said study co-author Dr. Steven Itzkowitz, director of the gastroenterology fellowship program at the Icahn School of Medicine at Mount Sinai in New York City.

    Though not yet approved for use by the U.S. Food and Drug Administration, the Cologuard test features a DNA analysis not included in other fecal exams.

    "By increasing the pick-up rate in this way," said Itzkowitz, "we found that the new test had a 92 percent sensitivity for detection of colorectal cancer."

    Last year, nearly 143,000 new cases of colorectal cancer were diagnosed in the United States and almost 50,000 Americans died of the disease, according to the U.S. National Cancer Institute. Yet, one-third of Americans fail to heed public health recommendations to undergo more invasive colonoscopy screenings every 10 years starting at age 50, Itzkowitz noted.

    Commonly used stool tests such as FIT (fecal immunochemical testing) rely on detecting blood in the stool. This new multi-target test checks for blood as well as abnormal DNA coming from the tumor, "with the advantage that some lesions, even cancers, don't bleed very much," Itzkowitz explained.

    The research, published in the March 19 issue of the New England Journal of Medicine, was funded by Exact Sciences Corp., the Wisconsin.-based maker of Cologuard.

    To assess the potential of the DNA method, nearly 10,000 men and women aged 50 and older were screened for colon cancer and precancerous polyps at one of 90 sites across the United States and Canada. All were considered at average risk for colon cancer.

    Each patient was screened three ways: by means of a standard colonoscopy; a commercially available fecal test (FIT); and the new DNA test, which requires patients to collect their own stool sample at home and mail it in for laboratory analysis.

    In the end, colonoscopy screenings -- considered the gold standard of colon cancer screening -- unearthed colon cancer in 65 participants, while another 757 were found to have advanced precancerous lesions.

    Today on WebMD

    Colorectal cancer cells
    The right diagnosis is the most important factor.
    man with a doctor
    Our health check will steer you in the right direction.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    doctor and patient
    Colorectal Cancer Therapy
     
    bread
    ARTICLE
    Colon vs Rectal Cancer
    VIDEO
     
    New Colorectal Treatments
    VIDEO
    can lack of sleep affect your immune system
    FEATURE
     
    Cancer Facts Quiz
    QUIZ
    Virtual Colonoscopy
    VIDEO
     
    Picture of the Colon
    ANATOMY
    Vitamin D
    SLIDESHOW